NCT04999787View on ClinicalTrials.gov

A Clinical Trial Evaluating the Efficacy, Safety, and Pharmacokinetics of HSK21542 Injection in Liver Disease Subjects With Pruritus

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 16, 2021

Primary Completion Date

August 3, 2022

Study Completion Date

August 3, 2022

Conditions

Pruritus

Interventions

DRUG

HSK21542

HSK21542-0.3 μg/kg，HSK21542-0.6 μg/kg

DRUG

Placebo

Trial Locations (1)

Unknown

The first hospital of Jilin University, Changchun

All Listed Sponsors

lead

Haisco Pharmaceutical Group Co., Ltd.

INDUSTRY

NCT04999787 - A Clinical Trial Evaluating the Efficacy, Safety, and Pharmacokinetics of HSK21542 Injection in Liver Disease Subjects With Pruritus | Biotech Hunter | Biotech Hunter